Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 06-2015 | 12-2014 | 06-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 40,210 | 13,930 | -17,300 | 0 | 1,250 |
| Depreciation Amortization | 4,280 | 2,600 | 5,270 | 0 | 6,720 |
| Other Working Capital | -14,370 | -5,820 | 4,940 | 0 | -3,910 |
| Other Operating Activity | 8,410 | 2,460 | 56,360 | 0 | 18,160 |
| Operating Cash Flow | $38,530 | $13,170 | $49,270 | $0 | $22,220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,350 | -610 | -1,810 | 0 | -3,590 |
| Other Investing Activity | -1,370 | -1,380 | -2,800 | 0 | -1,570 |
| Investing Cash Flow | $-6,720 | $-1,990 | $-4,610 | $0 | $-5,160 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -19,870 | -19,450 | -18,290 | 0 | -16,890 |
| Financing Cash Flow | $-19,870 | $-19,450 | $-18,290 | $0 | $-16,890 |
| Exchange Rate Effect | 1,370 | 910 | -160 | 0 | 0 |
| Beginning Cash Position | 49,530 | 49,620 | 26,200 | 0 | 25,660 |
| End Cash Position | 62,840 | 42,270 | 53,390 | 0 | 25,810 |
| Net Cash Flow | $13,300 | $-7,350 | $27,190 | $0 | $150 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,530 | 13,170 | 49,270 | 0 | 22,220 |
| Free Cash Flow | 38,530 | 13,170 | 49,270 | 0 | 22,220 |